Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Sun Pharmaceutical Industries Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	524715
ISIN Demat	INE044A01036
Book Value	103.25

NSE Code	SUNPHARMA
Dividend Yield %	0.76
Market Cap	4274055.35

P/E	135.69
EPS	13.13
Face Value	1


	BSE		NSE

07-May-2025

Last Price	1781.35
Net Change	-37.4
% Change	-2.06%
Prev.Close	1818.75
Open	1800.05
High	1825.00
Low	1778.85
Volume	43082

Last Price	1781.30
Net Change	-37.8
% Change	-2.08%
Prev.Close	1819.10
Open	1817.90
High	1826.40
Low	1778.70
Volume	2015237

Value	77222756
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1825.00
52-Week High	1960.20
52-Week Low	1376.75

Value	3607804178.1
Best Buy	0.00
Best Sell	1781.30
Best Quantity	0
Sell Quantity	222
Today's Range	1826.40
52-Week High	1960.35
52-Week Low	1377.20

Open Price	1825.00
High Price	1832.80
Low Price	1786.20
Last Price	1788.60
Prev Close	1822.90
Change	-34.30
% Change	-1.88 %

Average Price	1799.32
Underlying Value	1781.30
Number of contracts traded	5327
Turnover in Rs. Lakhs	33547
Open Interest	15453550.00
Change in O I	96600.00
% Change in O I	0.63 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	222
Price	1781.30

Best Bid

Best Offer

Quantity	350
Price	1787.1

Quantity	350
Price	1788

Holding Details

Latest Corporate Events

Bonus

1 : 1

29-Jul-13

Book Closure

25-Aug-21

31-Aug-21

Dividend

1050 %

06-Feb-25

Company News

24-04-2025

Sun Pharmaceutical Indust...

14-04-2025

Sun Pharmaceutical Indust...

11-04-2025

US court lifts restrictio...

11-04-2025

Sun Pharma surges after U...

07-04-2025

Sun Pharmaceutical Indust...

07-04-2025

Sun Pharma launches Fexup...

02-04-2025

Sun Pharmaceutical Indust...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.